Relative to patients with P14 and P53 negative cancers, patients with breast cancers displaying strong P14 and P53 expressions had an adjusted 3-fold increased risk of having disease recurrence (HR = 3.103, 95% CI: 1.539–6.256) (Table 4). This evidence concerns the gene TP53 and cancer.